Natural product-based therapy for Human cancer: Kefir, a traditional fermented milk product, inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 7/October/2014, 15.09

Anti-cancer stem cell therapeutics: Tumor suppressor ING1b inhibits mammary cancer stem cell proliferation via down regulation of Wnt receptor FZD7, 7/October/2014, 14.53
October 7, 2014
MiRNA-based therapy for Psoriasis: MiRNA-217 inhibits psoriasiform skin inflammation via down regulation of its target gene, 7/October/2014, 15.22
October 7, 2014
Show all

The 1989 Nobel prize winner in Physiology/Medicine Prof. Varmus Harold ESomwar R and others from High Throughput Screening Core Facility, and Organic Synthesis Core FacilityMemorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; and the US National Cancer Institute, USA has published a research paper in the 27 September 2011 issue of Proc Natl Acad Sci U S A. (I.F: >10) stating that “Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines.”  

Based on this this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: Natural product-based therapy for Human cancerKefir, a traditional fermented milk product, inhibits tumor cell proliferation via down regulation of  Superoxide dismutase 1 (SOD1).  This result  suggests that Kefir, by decreasing the expression of its target gene, it may decrease the expression of SOD1. Thereby, it may increase the levels of Superoxide anions in cancer cells, which in turn may increase the expression of a number of tumor suppressor genes.  Thus, pharmacological formulations encompassing Kefir may be used to treat human cancers.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

To citeBoominathan, Natural product-based therapy for Human cancerKefir, a traditional fermented milk product, inhibits tumor cell proliferation via down regulation of  Superoxide dismutase 1 (SOD1), 7/October/2014, 15.09,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.